BioProtect Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
130
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$270M
BioProtect General Information
Description
Developer of a pro-space balloon system designed to safely and temporarily separate the rectum during prostate cancer radiation therapy. The company's system acts as a spacer for the protection of healthy tissues in patients receiving radiotherapy for prostate cancer, enabling healthcare institutions to decrease the probability of serious and chronic radiation side effects while improving biochemical tumor control.
Contact Information
Website
www.bioprotect.com(Operating Subsidiary)
Corporate Office
- 8 Tsor Street
- Tzur Yigal 4486200
- Israel
Corporate Office
- 8 Tsor Street
- Tzur Yigal 4486200
- Israel
BioProtect Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Merger/Acquisition | 02-Jun-2026 | $270M | Completed | Generating Revenue | ||
| 16. Later Stage VC | 01-May-2025 | Completed | Generating Revenue | |||
| 15. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 14. Later Stage VC | 27-Sep-2023 | Completed | Generating Revenue | |||
| 13. Grant | 02-Mar-2023 | Completed | Generating Revenue | |||
| 12. Debt - General | 19-Aug-2022 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series D) | 21-Sep-2020 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 13-Apr-2017 | $3.62M | $12.8M | Completed | Generating Revenue | |
| 8. Later Stage VC (Series B) | 01-Jun-2016 | $500K | $9.2M | Completed | Generating Revenue |
BioProtect Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred C2 | ||||||||
| Preferred C1 | ||||||||
| Preferred B | ||||||||
| Preferred A4 | ||||||||
| Preferred A3 | ||||||||
| Preferred A2 | ||||||||
| Preferred A1 | 2,838 | $350 | $350 | 1x | $350 | 0.18% | ||
| Preferred A | 4,500 | $141.52 | $141.52 | 1x | $141.52 | 0.26% |
BioProtect Comparisons
Industry
Financing
Details
BioProtect Competitors (2)
One of BioProtect’s 2 competitors is Boston Scientific, a Corporation company based in Marlborough, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Boston Scientific | Corporation | Marlborough, MA | ||||
| IlluminOss | Private Equity-Backed | East Providence, RI |
BioProtect Patents
BioProtect Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026099743-A1 | Positioning a spacer inside a body | Pending | 08-Nov-2024 | ||
| US-20260033854-A1 | Positioning an inflatable bladder inside a body | Pending | 02-Aug-2024 | ||
| WO-2026028088-A1 | Positioning an inflatable bladder inside a body | Pending | 02-Aug-2024 | ||
| EP-4489700-A2 | Apparatus and method for protecting biological tissue during cryotherapy | Pending | 13-May-2022 | ||
| EP-4489700-A4 | Apparatus and method for protecting biological tissue during cryotherapy | Pending | 13-May-2022 | A61B18/02 |
BioProtect Signals
BioProtect Former Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AJJS Holdings | Venture Capital | Minority | ||
| Accelmed | Growth/Expansion | Minority | ||
| Almeda Ventures | Venture Capital | Majority | ||
| Aran Research Development & Prototypes | Corporation | Minority | ||
| Consensus Business Group | Asset Manager | Minority |
BioProtect FAQs
-
When was BioProtect founded?
BioProtect was founded in 2004.
-
Where is BioProtect headquartered?
BioProtect is headquartered in Tzur Yigal, Israel.
-
What is the size of BioProtect?
BioProtect has 130 total employees.
-
What industry is BioProtect in?
BioProtect’s primary industry is Therapeutic Devices.
-
Is BioProtect a private or public company?
BioProtect is a Private company.
-
What is the current valuation of BioProtect?
The current valuation of BioProtect is .
-
What is BioProtect’s current revenue?
The current revenue for BioProtect is .
-
How much funding has BioProtect raised over time?
BioProtect has raised $67.9M.
-
Who are BioProtect’s investors?
AJJS Holdings, Accelmed, Almeda Ventures, Aran Research Development & Prototypes, and Consensus Business Group are 5 of 23 investors who have invested in BioProtect.
-
Who are BioProtect’s competitors?
Boston Scientific and IlluminOss are competitors of BioProtect.
-
When was BioProtect acquired?
BioProtect was acquired on 02-Jun-2026.
-
Who acquired BioProtect?
BioProtect was acquired by Olympus (Diagnostic Equipment).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process